Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS

FP7

Myasterix

Project reference: 602420
Funded under

Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis

From 2013-10-01 to 2018-09-30, ongoing project

Project details

Total cost:

EUR 7 538 399,15

EU contribution:

EUR 5 900 720

Coordinated in:

France

Call for proposal:

FP7-HEALTH-2013-INNOVATION-1See other projects for this call

Funding scheme:

CP-FP - Small or medium-scale focused research project

Objective

Related information

Coordinator

INSERM - TRANSFERT SA
France

EU contribution: EUR 355 284,16


Rue Watt 7
75013 PARIS
France
Administrative contact: Florence Chung
Tel.: +33 155030122
Fax: +331 55 03 01 60
E-mail

Participants

CURAVAC EUROPE SPRL
Belgium

EU contribution: EUR 2 101 840,4


AVENUE DE VILLEFRANCHE 80
1330 RIXENSART
Belgium
Administrative contact: Nicolas Havelange
Tel.: +32 486367961
E-mail
piCHEM Forschungs und Entwicklungsgmbh
Austria

EU contribution: EUR 1 162 000


Kahngasse 20
8045 Graz
Austria
Administrative contact: Fritz Andreae
Tel.: +43 31668171111
Fax: +43 3166817114
E-mail
ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands

EU contribution: EUR 1 061 595,84


ALBINUSDREEF 2
2333 ZA LEIDEN
Netherlands
Administrative contact: Jan Verschuuren
Tel.: +31 715262197
E-mail
AEPODIA SA
Belgium

EU contribution: EUR 779 999,6


RUE LOUIS DE GEER 6
1348 OTTIGNIES LOUVAIN LA NEUVE
Belgium
Administrative contact: Charlotte Cuvelier
Tel.: +32 10392013
E-mail
Universitair Ziekenhuis Antwerpen
Belgium

EU contribution: EUR 440 000


Wilrijkstraat
2650 Edegem
Belgium
Administrative contact: Daisy Van Mieghem
Tel.: +3238213191
E-mail

Subjects

Life Sciences
Record Number: 110173 / Last updated on: 2016-03-31